abstract |
The present invention relates to a novel substituted fused pyrimidine compound of the formula (I)nâ–ˇnWherein the chemical group, substituent and index are as defined in the specification, and for their use as a medicament, in particular for the treatment of conditions and diseases which can be treated by inhibition of PDE4 enzyme. |